Diving into Complex Durable Medical Equipment Needs: The Multiple Sclerosis at Home Access Program (MAHA)
Background: Updated prevalence estimates indicate that nearly 1 million Americans are living with MS including a large cohort of aging...
Recently Diagnosed Early-Stage RRMS: Neda, ARR, Disability Progression, Serum Neurofilament and Safety: 1-Year Interim Data from the Ocrelizumab Phase IIIb ENSEMBLE Study
Background: Early treatment of multiple sclerosis (MS) and rapid onset of therapeutic effect provide long-term benefits on disease...